US pharma firm to build manufacturing plant in Ireland

US pharma firm Aerie has earmarked proceeds from the $125m it has raised in stock market sales for the construction of an Irish manufacturing facility.
The plant is expected to serve the $1bn company's international and US markets, the Irish Independent reports.